These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33387024)

  • 21. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
    Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
    Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
    Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with middle and distal bile duct cancers.
    Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
    World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
    Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
    J Surg Oncol; 2020 Dec; 122(7):1516-1517. PubMed ID: 32960983
    [No Abstract]   [Full Text] [Related]  

  • 26. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent.
    Takahashi T; Kawaji H; Murakawa Y; Hayashizaki Y; Murakami T; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Eur J Surg Oncol; 2021 Feb; 47(2):394-400. PubMed ID: 32878723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.
    Nakeeb A; Pitt HA; Sohn TA; Coleman J; Abrams RA; Piantadosi S; Hruban RH; Lillemoe KD; Yeo CJ; Cameron JL
    Ann Surg; 1996 Oct; 224(4):463-73; discussion 473-5. PubMed ID: 8857851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
    Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection.
    Otsuji H; Yokoyama Y; Ebata T; Igami T; Sugawara G; Mizuno T; Nagino M
    World J Surg; 2015 Jun; 39(6):1494-500. PubMed ID: 25651963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.
    Suzuki S; Kajiyama H; Shimoda M; Shimazaki J; Koike N; Harada N
    Dig Surg; 2017; 34(6):476-482. PubMed ID: 28166534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major hepatectomy for perihilar cholangiocarcinoma.
    Unno M; Katayose Y; Rikiyama T; Yoshida H; Yamamoto K; Morikawa T; Hayashi H; Motoi F; Egawa S
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):463-9. PubMed ID: 19941010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of inflammatory and nutritional markers as prognostic predictors in patients with resected distal cholangiocarcinoma.
    Kitasato A; Kuroki T
    Asian J Surg; 2021 Dec; 44(12):1574-1576. PubMed ID: 34503876
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
    Han Y; Zhang W; Liu Y
    World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.
    Okada R; Shimada H; Otsuka Y; Tsuchiya M; Ishii J; Katagiri T; Maeda T; Kubota Y; Nemoto T; Kaneko H
    Surg Today; 2017 Dec; 47(12):1492-1499. PubMed ID: 28508195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual Carcinoma In Situ at the Ductal Stump has a Negative Survival Effect: An Analysis of Early-stage Cholangiocarcinomas.
    Tsukahara T; Ebata T; Shimoyama Y; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nagino M
    Ann Surg; 2017 Jul; 266(1):126-132. PubMed ID: 27501166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
    Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
    Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma.
    Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.